Back to Search
CHRISTOPHER MCDOUGLE, M.D.
M.D.
Child & Adolescent Psychiatry Physician
NPI: 1871547497IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry Physician
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
01047650(IN)
Child & Adolescent Psychiatry PhysicianPrimary
Psychiatry & Neurology — Child & Adolescent Psychiatry
Code: 2084P0804X
01047650(IN)
CMS Specialties
PrimaryPSYCHIATRY
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 1986
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).
PMID 37811711·Cochrane Database Syst Rev·2023
1-meta
A prospective open trial of guanfacine in children with pervasive developmental disorders.
PMID 17069547·J Child Adolesc Psychopharmacol·2006
4-observational
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
PMID 18533764·J Clin Psychiatry·2008
6-review
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
PMID 15930063·Am J Psychiatry·2005
3-trial
Treatment of aggression in children and adolescents with autism and conduct disorder.
PMID 12672261·J Clin Psychiatry·2003
6-review
Genetics of childhood disorders: XLIV. autism, part 3: psychopharmacology of autism.
PMID 12410082·J Am Acad Child Adolesc Psychiatry·2002
8-other
Case series: use of ziprasidone for maladaptive symptoms in youths with autism.
PMID 12164181·J Am Acad Child Adolesc Psychiatry·2002
8-other
Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.
PMID 11098879·J Autism Dev Disord·2000
8-other
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
PMID 10674197·Child Adolesc Psychiatr Clin N Am·2000
6-review
A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
PMID 10920469·Arch Gen Psychiatry·2000
3-trial
Serotonin and dopamine transporter binding in children with autism.
PMID 18754890·Dev Med Child Neurol·2008
8-other
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.
PMID 18791817·J Autism Dev Disord·2009
4-observational
Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.
PMID 19057413·J Am Acad Child Adolesc Psychiatry·2009
4-observational
Trial design challenges when combining medication and parent training in children with pervasive developmental disorders.
PMID 19096921·J Autism Dev Disord·2009
2-rct
A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder.
PMID 19148734·J Autism Dev Disord·2009
2-rct
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes.
PMID 19404257·Nature·2009
8-other
Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials.
PMID 19681003·J Intellect Dev Disabil·2009
4-observational
Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.
PMID 19519261·J Child Adolesc Psychopharmacol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 702 BARNHILL DR
INDIANAPOLIS, IN 46202 - Phone
- (317) 274-3960
Quick Facts
- NPI
- 1871547497
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 40
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile